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Abstract
The formation of calcium (Ca) stones occurs in an initial phase by fixed growth on kidney 
calcifications consisting either of intratubular crystal accumulations protruding in renal 
calices (Randall’s plugs) or of interstitial hydroxyapatite deposits (Randall’s plaques) 
broken through the covering epithelial layers. Crystal aggregation (AGN) seems to be 
responsible for stone growth during crystalluria. This chapter reports on new aspects 
of the AGN of calcium oxalate being the most frequent stone compound and tries to 
explain why despite the widespread occurrence of kidney calcifications and crystallu-
ria not everybody forms stones. Urinary crystals normally are protected from AGN by 
coats of urinary macromolecules (UMs) which by their identical electronegative charge 
create zones of electrostatic repulsion. At high urinary concentration or ionic strength 
respectively, these zones are compressed and can be bridged by self-aggregated UMs. 
Self-AGN occurs in concentrated urine by the adsorption of UMs on free surfaces like 
Randall’s plugs or plaques. High oxalate excretion and high urine concentration favor-
ing intratubular crystal accumulation, breaking of epithelial layers on Randall’s plaques 
and self-AGN of UMs are most deleterious factors in Ca stone formation and have to be 
avoided by stone metaphylaxis.
Keywords: calcium nephrolithiasis, crystalluria, Randall’s plaques and plugs, urinary 
macromolecules, calcium oxalate aggregation
1. Introduction
The pathogenesis of kidney stones that often are accompanied by very painful colic and 
can lead to renal failure and even to the loss of a kidney is far from being clear. In Western 
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 populations, nephrolithiasis has reached a prevalence up to 10% [1]. Kidney stones are com-
posed of crystal aggregates within an organic matrix. Long times stone formation mainly was 
ascribed to a pathological excretion of substances being involved in crystal formation. Fourier 
transform infrared spectroscopy being now commonplace for stone analysis shows that cal-
cium oxalate (CaOx) is the most frequent stone compound. For calcium nephrolithiasis, the 
most frequent stone disease and the topic of this chapter, the important substances are cal-
cium, oxalic and citric acid the latter being a calcium chelator [2]. However, not all stone form-
ers show a pathological excretion of these compounds, and some anomalies also are found 
in urine of people without stone formation. Later on, stone research was focused on urinary 
macromolecules (UMs, mainly proteins and some glycosaminoglycans) being an integral part 
of the stone matrix and some of them promoting or inhibiting the crystallization of stone min-
erals [3]. In the meantime, more than 70 of such substances were isolated [4, 5], and 11 of them 
containing anionic residues like carboxyglutamic acid, phosphate and sialic acid are thought 
to be relevant for stone formation [6]. But anomalies with respect to excretion or composition 
of these UMs were exclusively found in some small groups of patients [7].
Modern urological endoscopy which allows the inspection of the whole renal cavity showed 
that calcium oxalate and phosphate stones comprising about 80% of all concretions [8] gen-
erally start by a fixed growth on papillary calcifications, which were already described as 
potential source of nephrolithiasis in 1937 by Randall [9]. Recently much work was done to 
elucidate the pathogenesis of these calcifications being present either as interstitial deposits 
of calcium phosphate (Randall’s plaques) or as intratubular accumulation of calcium oxalate 
crystals (Randall’s plugs) [10–12]. These calcifications when protruding into renal calyces can 
induce stone formation either by heterogeneous nucleation of new crystals or more probably 
by the aggregation (AGN) of crystals during crystalluria. The initial fixation on kidney calci-
fications allows stones to grow to a critical size where they cannot be washed out anymore by 
the urine flow and where they become symptomatic. However, the finding of kidney calcifica-
tions and crystalluria is much more frequent than stone disease [3], and Randall’s plaques can 
persist during some decades without or with only minimal stone formation [13]. Therefore, 
the question raises whether special crystallization conditions in urine might be responsible 
for stone formation by the apposition of new crystals on Randall’s plaques and plugs. This 
question stimulated us to an intensive study of the formation and especially the AGN of 
calcium oxalate crystals being with 60% the most frequent stone compound [8]. Experiments 
were directly performed in urine where like in other biological mediums, crystals as well as 
Randall’s plaques and plugs always are coated by proteins [14]. Instead of the study of indi-
vidual compounds thought to be involved in stone formation, the overall effect of UMs was 
compared to that one of urine and urinary ultrafiltrate. UMs were isolated either by a hemo-
filtration procedure or by temporary adsorption on Ca phosphate to which urinary proteins 
have a high affinity.
2. Measurement of calcium oxalate (CaOx) crystallization in urine
An approved test system which uses an increase of the rate of particle sedimentation as  measure 
for crystal AGN was modified [15]. Contrary to current crystal production in  standardized and 
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protein-free solutions and with a long period of crystal ripening, CaOx was directly produced 
in urine by an oxalate titration [16]. Crystallization was followed monitoring optical density 
(OD) by a spectrophotometer. Typical crystallization curves are shown in Figure 1A and C. 
During a titration period of 15 min with the addition of 0.1 mM/min of sodium oxalate, a rapid 
increase of OD indicating crystal formation is observed. From the time lag of this increase, the 
critical oxalate addition to induce crystallization can be calculated and used as a measure for 
the metastability of urine with respect to CaOx crystallization. At the end of titration, maximal 
OD reflecting particle concentration in solutions [15] is determined, and magnetic stirring is 
stopped. Following the further course during at least 30 min, two different types of curves are 
observed. One type (Figure 1A) is characterized by a continuous slow OD decrease, which by 
scanning electron microscopy (SEM) of the sediment (Figure 1B) mainly can be attributed to 
the sedimentation of single crystals of CaOx monohydrate. From this low −mdOD/dt, the sedi-
mentation rate of single crystals and an average particle size can be calculated [17]. The other 
type of curve is represented in Figure 1C. After an initial phase of slow OD decrease varying 
from 7 to 35 min and called suspensions stability, a rapid decline of OD is observed which by 
SEM of the sediment (Figure 1D) can be attributed to crystal AGN. Since OD mainly reflects 
particle concentration, the rapid OD decrease can be explained by an increased particle clear-
ing in the observation field of the spectrophotometer. This high clearing bases on the one hand 
on an accelerated sedimentation of crystal aggregates (the sedimentation rate increases with 
particle diameter in square) and on the other hand on the diminution of particle concentration 
by the integration of a lot of single crystals into few large aggregates. Interestingly, the rapid 
Figure 1. Crystallization curves (CC) of urine and scanning electron microscopy (SEM) of sediments: (A) urine with 
inhibition of CaOx AGN in CC (low maximal rate of OD decrease, −mdOD/dt) and (B) mainly with single crystals of 
CaOx monohydrate and only a few small aggregates in SEM, (C) urine with intensive AGN (high −mdOD/dt) in CC, and 
(D) large aggregates predominating in SEM. Bars on SEM indicating 20 μm.
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OD decrease reflecting AGN stops after on average 30% of OD has disappeared by AGN [16]. 
Therefore, AGN in crystal suspensions seems to be limited to a critical OD or particle concen-
tration. The maximal OD decrease observed in our experiments is expressed as maximal OD 
change per minute (−mdOD/dt).
UM solutions and urinary ultrafiltrate (UF) were obtained using a hemofilter the excluding 
limit of the dialysis membrane being 5 kDa [18]. To gain UF urine was placed on one side of the 
membrane and the filtrate collected on the other side. UMs were isolated by dialyzing urine 
against bi distilled water. This procedure showed a volume recovery of 96% and thus allowed 
the isolation of UMs in their almost original concentration. UM solutions also were prepared 
by Ca phosphate precipitation in urine, which was induced by the addition of sodium hydro-
gen phosphate at pH 7.0 [19]. After centrifugation and discharge of the supernatant, the pre-
cipitate was dissolved in distilled water buffered to pH 5.0 and with a volume corresponding 
to the urine volume used for precipitation. To obtain comparable results experiments in urine, 
ultrafiltrate and UM solutions were performed at identical pH, Na, and Ca concentration.
3. Crystallization conditions of CaOx in urine and within the kidney
CaOx crystallization in urine is a complex process. It occurs when the product of ion activi-
ties of Ca and oxalic acid (Ca
a
 × Ox
a
) exceeds a critical value called formation product (FP). 
In filtered urine, this FP was found to be very high. It exceeded about 14 times the product 
of ion activities (Ca
e
 × Ox
e
) observed in urine after equilibration with CaOx crystals in excess, 
the ratio Ca
a
 × Ox
a
/Ca
e
 × Ox
e
 being a measure for the state of saturation [2]. Ion activities 
and thus crystallization tendency of calcium and oxalic acid are reduced by the formation of 
highly soluble complexes of Ca with citric acid and of Ox with magnesium. These complexes 
reduce the concentrations of Ca and Ox being disposable for crystallization. The influence of 
stone forming substances, chelators, and pH on the state of urinary saturation with respect to 
CaOx can be calculated by special computer programs [20] or experimentally be tested [21]. 
Equilibration experiments performed with CaOx crystals in 76 urines from recurrent calcium 
stone formers demonstrated that supersaturation with respect to CaOx was only significantly 
(p < 0.001) correlated with urinary Ox concentration. The same experiments performed with 
brushite on the other hand showed that Ca phosphate saturation mainly is governed by Ca 
concentration and pH. Also clinical observations demonstrated that hyperoxaluria generally 
is much more important for the genesis of CaOx stones than hypercalciuria [22]. In 60 urines, 
an average addition of 0.64 mM Ox without a significant difference between stone patients 
and controls was necessary to induce CaOx crystallization [16]. Such high urinary Ox concen-
trations are apart from rare cases of primary hyperoxaluria exclusively observed after exces-
sive Ox ingestion [23]. Nevertheless, crystalluria is a frequent finding. Crystals are found in 
9–48% urines of stone patients and in 2–26% of healthy controls [24]. The discrepancy between 
clinical and experimental observations can be explained by heterogeneous crystal nucleation 
where preformed surfaces of Ca phosphate crystals, damaged renal tubular cells, and cellular 
debris in urine [3] allow the formation of CaOx far below the high FP necessary for spontane-
ous nucleation. Cellular debris comprises about 50% of urinary deposits [25].
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For stone formation, crystals have to be retained in the kidney. This seems for single crys-
tals hardly to be possible. In the nephron, Ox normally reaches a sufficient concentration for 
CaOx crystallization at the end of collecting ducts (CD), but at extremely high Ox concen-
trations, crystallization already can occur in the descending loop of Henle (DLH) [26]. Both 
situations are schematically indicated in Figure 2. Even at the high Ox concentrations neces-
sary to induce crystal formation in DLH crystallization is a relative slow process compared 
to urinary transit time (UT) through the nephron. Following CaOx crystallization in urine 
by repeated measurement of the ionic Ca decay by a ion selective electrode shows that even 
after an extreme Ox addition of 1 mM crystallization reaches during an average transit time 
through the nephron of 3 min only about half of its final value (Figure 3). The figure demon-
strates that the study of crystals in urine which previously has remained several times in the 
bladder hardly can be representative for the situation in the kidney. For the end of the neph-
ron when crystals have passed inner tubular diameters of minimal 15–60 μm, maximal crystal 
diameters of 4 μm were calculated [27]. The discrepancy of crystals size and tubular dimen-
sions is even more pronounced when crystallization starts at the end of collecting ducts where 
crystals only can grow during a few seconds until they reach the renal papilla (Figure 2). 
Therefore, for the formation of obstructing plugs, crystals have to aggregate as demonstrated 
Figure 2. Localization of CaOx crystallization in the nephron (hatched areas): descending loop of Henle (DLH), collecting 
duct (CD), renal papilla (RP), maximal crystal diameter (DCr) expected at nucleation site (a), at RP (b), minimal inner 
tubular diameter (DT), urinary transit time (UT) to RP.
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by the finding of large crystal aggregates on micro photographs of Randall’s plugs [10]. AGN 
also seems to be responsible for the acquisition of CaOx on Randall’s plaques and generally 
for the growth of calcium stones [28].
4. Crystal aggregation (AGN) in urine and within the kidney
Already in 1969, crystal AGN was found to be an important element in stone formation. In 
a study of six patients with short-term stone recurrence and six healthy controls, patients 
showed contrary to the controls 3 h after Ox ingestion large CaOx aggregates with diameters 
up to 200 μm in their urine [29]. However, in our crystallization test, AGN could also be pro-
duced by high Ox addition in 11 urines of 30 healthy people but less frequent than in urine of 
unselected stone patients (20/30, p < 0.05) [16]. Interestingly, this AGN started with a delay of 
15–35 min being not only beyond the average urinary transit time (UT) of 3 min in the neph-
ron but also beyond an average UT in the renal pelvis of 12 min [30]. Crystal AGN seems thus 
to depend on urinary Ox or crystal concentration respectively and on an induction time also 
called suspensions stability.
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Figure 3. Ionic Ca (Ca2+) decay after addition of 1 mM Ox to urine: half time (•) and endpoint of crystallization (dashed 
line), average urinary transit time through the nephron (UTN).
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For AGN, particles have to collide. Under physiological conditions (without stirring or shak-
ing), this collision occurs by particle sedimentation or Brownian motion (diffusion). At maxi-
mal crystal concentrations of 24,000 crystals/ml being observed during crystalluria [27], only 
2.5 × 10−5 collisions per minute can be expected by diffusion within the short UT through the 
nephron [17]. Sedimentation on the other hand can accumulate under these conditions on a 
tubular wall being in horizontal position 1.3 crystals/min and on kidney calcifications or stone 
surfaces 624 crystals/cm2 and minute. These accumulation rates are positively correlated with 
particle diameter in square and particle concentration whereas collision rates increase by par-
ticle concentration in square [17]. To get some insight in AGN processes within an appropri-
ate observation time, studies have to be performed in highly concentrated crystal suspensions 
where AGN mainly occurs on the basis of diffusion. For the measurement of CaOx AGN in 
urine, Ox additions of 1.5 mM were necessary. Even under these extreme conditions, urine 
showed a high inhibitory activity with respect to CaOx AGN. AGN only was observed in 31 
of 60 urines and always with some delay [16].
Inhibition of AGN can be ascribed to an electrical surface potential which allows identically 
charged particles only to near to critical distance where diffusion or sedimentation is com-
pensated by electrostatic repulsion [31]. Also lower surface potentials act as intermediate bar-
rier, which slows down AGN by the fact that numerous attempts are necessary to overcome 
electrostatic repulsion. This may explain the delay of AGN which was always observed in 
urine. In urine, crystals are coated by urinary macromolecules (UMs) which provide by their 
anionic residues an electronegative surface potential in the order of −15 mV [18]. Scanning 
electron microscopic pictures of CaOx crystals being incubated in albumin or globulin 
solutions showed protein coats on the crystals with diameters of 10–20 nm [14]. UM coats 
can be composed as mentioned in the Introduction by more than 70 different proteins [5]. 
Confronted with such multiple substances often with an unknown influence on crystalliza-
tion processes, we decided to center our studies on whole urine, on UM solutions which were 
directly isolated from urine and on albumin being a frequent compound of urinary crystals 
and stones [3].
Although the adsorption of proteins like prothrombin fragment 1 and albumin was ascribed 
to a face-specific interaction between Ca in the lattice of CaOx crystals and selected anionic 
groups in the proteins [32], the coating of surfaces by UMs can also be a rather unspecific pro-
cess. As Figure 4 shows, not only crystals but also latex beads can be easily coated by UMs. 
This coating bases on a hydrophobic effect between proteins and latex. By Zetasizer analysis, 
latex beads showed after the incubation in UM solutions, an increase of particle diameters by 
40 μm corresponding to an UM coat of 20 μm. A pH change in the UM solution from 6.0 to 
5.0 diminished the negative surface potentials of the coated beads from −34 to −24 mV and 
produced a massive increase of particle diameters or AGN, respectively. This pH effect which 
bases on a reduced ionization of the anionic protein residues by an increased H+ concen-
tration demonstrates that surface potentials are essential for the inhibition of AGN. Further 
experiments which were performed with latex beads in almost electrolyte and especially 
Ca-free albumin solutions showed that the AGN of UM-coated particles too can base on a 
hydrophobic effect [19].
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Figure 4. Affinity of urinary macromolecules (UMs) to latex beads (LBs) measured by particle size distribution (PSD) 
within a 2-min interval: (A) PSD of LBs before incubation in UM solution, (B) after incubation, (C) pH change from 6.0 to 
5.0 in suspension of latex in UM solution showing from the left to the right curve a progressive increase of particle size 
due to AGN of the coated latex beads.
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Pathological UMs with reduced anionic groups are found to be responsible for crystal 
AGN in urine [33–35] and were observed in urine of some stone patients [36–38]. However, 
also dialysis in a hemofilter abolishes the inhibitory activity of UMs [16]. All UM solu-
tions obtained by dialysis from 29 urines with previously low maximal sedimentation 
rates showed a massive increase of −mdOD/dt indicating AGN (Figure 5). In order to find 
low molecular weight substances which might be responsible for the inhibition of AGN, 
crystallization tests were repeated in urinary ultrafiltrate (UF) with an identical result as 
obtained in the UM solution. Also a loss of important substances by the adsorption on 
the large surface of the hemofilter could be excluded by repeating crystallization tests 
in UM solutions where UMs were isolated only by temporary adsorption on Ca phos-
phate and consecutive dilution as described above. Further experiments performed with 
albumin brought an explanation for this peculiar loss of AGN inhibition after temporary 
contact with large surfaces. Albumin at high concentration has a tendency to self-AGN 
[39], which is demonstrated in Figure 6A. By the measurement of particle size distribution 
(PSD) immediately after the preparation of an albumin solution (AS) in a high urinary 
concentration of 20 mg/l, a main peak at 10 nm being typical for albumin and a lower sec-
ond peak around 1000 nm were found. Two minutes later, the main peak was somewhat 
diminished and peaks around 350 and 4100 nm became visible indicating progressive 
self-AGN of albumin. However, in the CaOx crystallization test performed in AS, only a 
minimal acceleration of sedimentation was observed (Figure 7A). The diluted Ca phos-
phate precipitate of AS on the other hand showed in PSD that all extracted albumin was 
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Figure 5. Effect of UM isolation on inhibition of CaOx AGN (low −mdOD/dt): native urine (NU), dialysed urine (DU), 
ultrafiltrate (UF), and dissolved Ca phosphate precipitates of urine (DP) (n = 29, x ± SD, NU vs. DU, UF and DP p < 0.001).
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aggregated into a high single peak at 480 nm (Figure 6B) and in the crystallization test, a 
rapid OD decrease being characteristic for intensive crystal AGN was found (Figure 7B). 
These observations demonstrate that crystal AGN also occurs in the presence of normal 
but self-aggregated UMs. UM aggregates with increasing size like aggregated albumin 
obviously can bridge critical distances of electrostatic repulsion and connect crystals prob-
ably by hydrophobic binding to their UM coats. Scanning electron microscopy of Ca Ox 
crystals being incubated in gamma globulin solutions showed at crystal convergence of 
some aggregates large amounts of amorphous material suggesting a crystal binding by 
aggregated proteins [14].
The formation of Randall’s plugs seems to be a product of crystal AGN. Randall’s plugs are 
observed as origin of kidney stones at states of massive chronic supersaturation of urine either 
with respect to CaOx as found in primary hyperoxaluria or with respect to Ca phosphate 
in primary hyperparathyroidism [40]. Under these conditions, crystallization as mentioned 
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Figure 6. Particle size distribution (PSD) of albumin: (A) PSD in albumin solution in high urinary concentration (AS, 
20mg/l) and (B) PSD in dissolved Ca phosphate precipitate of AS (DPA).
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above already can start in DLH. During their way through the nephron, crystals can drop 
by sedimentation on tubular walls where they stick and together with following crystals can 
form large crystal accumulations. Such accumulations probably are an ideal platform for the 
adsorption and self-AGN of UMs. Massive crystalluria and even hyperoxaluria are known to 
damage tubular cells and thus to favor the sticking of crystals on tubular walls [41]. Damaged 
tubular cells produce pathological proteins which also favor this sticking and the AGN of the 
crystals [3]. Furthermore, basement membrane denuded by its epithelial layer can induce het-
erogeneous nucleation of CaOx [42]. These mechanisms can provoke massive crystal aggre-
gates which protruding from ducts of Bellini into renal calices can raise stone formation in the 
kidney as observed by urological endoscopy [40].
5. CaOx AGN in the presence of hydroxyapatite (HAP), a possible  
model for stone formation on Randall’s plaques (RPLs)
Idiopathic Ca nephrolithiasis where by definition no metabolic or endocrinologic disor-
ders like primary hyperoxaluria or hyperparathyroidism are found is the most frequent 
stone disease and generally starts by stone growth on RPLs [10–12, 40]. RPLs are subepi-
thelial deposits of Ca phosphate in the renal papilla which by disruption of the covering 
epithelial layer can come in contact with urine and give raise to stone growth. The Ca 
phosphate deposits, mainly HAP, are a consequence of the transformation of epithelial 
cells into an osteoplastic phenotype with an increased production of bone-specific  proteins 
Figure 7. Crystallization curve of AS and DPA: AS shows with a relative low −mdOD/dt inhibition of CaOx AGN, and a 
high −mdDO/dt in DPA indicates massive AGN (n = 5, x ± SD, p < 0.01).
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like osteopontin (OP) favoring tissue mineralization [12]. Histological analysis with immu-
nohistochemistry or infrared spectroscopy of RPLs with an adherent stone showed that 
the RPLs consisted of an OP matrix with HAP deposits, whereas the adherent stone in 
addition to OP and HAP contained Tamm-Horsfall glycoprotein (THG) and CaOx crystals 
[40]. Stone formation on RPLs thus seems to occur at the interface of HAP and CaOx crys-
tals being embedded in proteins like OP and THG which like albumin have a tendency to 
self-AGN [3]. The osteoplastic transformation of epithelial cells which mainly occurs in 
the loop of Henle was ascribed to vascular or metabolic disorders since in epidemiological 
studies, stone disease was found to be associated with hypertension, myocardial infarc-
tion, diabetes, or metabolic syndrome [12]. However, RPLs seem to be very frequent and 
not always associated with stone disease. High-resolution radiography of 50 consecutive 
sets of cadaveric kidneys showed in 57% radiographic evidence consistent with RPLs [43]. 
In an older study, in all kidneys of 100 randomly selected autopsies, some papillary calci-
fications were found but only in seven cases of kidney stones [44]. Urological endoscopy 
revealed RPLs even in 43% of cases not being related to stone disease [45]. The mechanisms 
involved in the progression of a RPL to a kidney stone are far from being clear. One of 
these processes is breaking of epithelial layers, which brings the calcifications of RPLs in 
contact with pelvic urine [12]. A further unknown factor is the formation of CaOx crys-
tals on the denuded and protein-coated HAP of RPLs. Therefore, we tried to mimic this 
formation by the study of CaOx crystallization in the presence UM-coated HAP (cHAP). 
Contrary to previous studies performed immediately after thawing of frozen urine, 15 
freshly voided urines of five healthy men were examined.
To prepare cHAP, commercially available HAP crystals (0.05 mg/ml) were incubated at 37° 
during at least 30 min in one portion each of 15 urines from healthy persons [46]. After 
centrifugation and discharge of the supernatant, the crystals were suspended in a second 
portion of the same urine. Ca and pH were adapted to the standard values of 2 mM and 
6.0, respectively, used in the tests. CaOx crystallization tests as described above were per-
formed in urine with and without the cHAP suspension. By this procedure, a high −mdOD/
dt indicating AGN was observed in 8 of 15 urines performed with cHAP, whereas in the test 
performed without cHAP, only one of the 15 urines showed a high −mdOD/dt. Interestingly, 
urines with and without cHAP-induced AGN significantly (p < 0.01) could be distinguished 
by their sodium concentration (Figure 8) being an indicator for urinary ionic strength [47]. A 
high ionic strength seems to favor AGN, whereas urine dilution abolished the cHAP-induced 
AGN. All urines with an initially high −mdOd/dt showed after dilution and adaption of Ca 
and pH to the initial values only a slow OD decrease being typical for the sedimentation of 
single crystals without AGN. Urinary dilution down to 33% did not disturb urinary inhibi-
tory activity with respect to not cHAP-related CaOx AGN, which is in agreement with the 
finding that urine even diluted to 20% is still an excellent inhibitor of the AGN of CaOx crys-
tals [48]. The promotion of AGN by a high ionic strength can be explained by its influence on 
the extension on electrostatic surface potentials (ESPs). In electrolyte-containing solutions, 
ESP exponentially decreases with increasing distance from negatively charged particles by 
a cation accumulation (in our experiment of sodium) [31]. In concentrated urine with a high 
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ionic strength, ESP is compressed to a few nanometers where crystals can approach to dis-
tances where self-aggregated UMs can take over their bridging effect.
To get more information about CaOx AGN being induced by cHAP, supplementary experi-
ments were performed in solutions of albumin in a high urinary concentration (AS, 20 mg/l). 
The comparison of experiments performed in AS and in concentrated urine showed almost 
identical results (Figure 9). A high inhibitory activity with respect to CaOx AGN of AS and 
urine was abolished by the cHAP addition and also in the dissolved Ca phosphate precipi-
tates (DPs) of urine and AS. Under the special conditions of our experiments, albumin seems 
to be an ideal substance to mimic UM effects. Adsorption on surfaces favors self-AGN of 
UMs as demonstrated with respect to albumin and thus can turn inhibitors to promoters of 
AGN [46]. Ca phosphates are excellent substrates for UM adsorption [5]. HAP of RPLs being 
denuded from their epithelial cells is therefore an ideal platform to initiate stone formation by 
the adsorption and self-AGN of UMs. Since the effect of UMs or albumin on CaOx AGN was 
identical when adsorbed on HAP or when being in solution after temporary adsorption, HAP 
of RPLs is more likely to act as a mediator of crystal AGN than as a heterogeneous nuclea-
tor for CaOx formation as suggested by others [12]. Indeed, scanning electron microscopy 
of urinary sediments after HAP-induced CaOx AGN showed in agreement with findings on 
RPLs large CaOx aggregates which were in the surroundings but not in direct contact with 
the HAP crystals [49].
Figure 8. CaOx AGN (increase of −mdOD/dt) induced by UM-coated hydroxyapatite (cHAP) in urine: crystallization 
test without (o) and with the addition of 0.05 mg/ml cHAP (•) at low and at high sodium concentrations (Na) and after 
urinary dilution (UD) (n = 8, x ± SD).
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6. Summary and conclusions
The formation of Ca stones in the kidney during crystalluria seems to base on crystal AGN 
either on Randall’s plugs or on plaques. Urine has, as demonstrated by our study, a high 
inhibitor capacity with respect to CaOx AGN. Coating of crystals by electronegative charged 
UMs creates zones of electrostatic repulsion between the crystals which under normal condi-
tions and within the short urinary transit time in the kidney hardly can be overwhelmed by 
diffusion or sedimentation being responsible for particle collision and thus AGN. Zones of 
electrostatic repulsion are reduced in the presence of pathological UMs with a lack of anionic 
residues or in concentrated urine with a high ionic strength. UMs with a lack of negatively 
charged anionic groups create an insufficient surface potential on UM-coated crystals. At high 
ionic strength, the extent of surface potentials is compressed by an increased accumulation 
of cations. Under these conditions, zones of electrostatic repulsion probably can be bridged 
by normal but self-aggregated UMs. Self-AGN occurs by the adsorption of UMs on surfaces 
especially of HAP with its high affinity to UMs. The AGN of UM-coated particles like uri-
nary crystals or latex beads probably mainly bases on a hydrophobic effect between the large 
hydrophobic protein segments. This effect can occur either directly between pathological UM 
coats or is mediated by self-aggregated but normal UMs.
Stone formation on Randall’s plugs mainly occurs at high urinary supersaturation with 
respect to Ca salts as observed in primary hyperoxaluria or in hyperparathyroidism both with 
Figure 9. Almost identical results obtained in crystallization test (CT) performed with concentrated urine (•) and 
albumin solution (AS, 20 mg/l (o): CT performed in native urine or AS (native), in urine or AS with UM or albumin 
coated HAP (+cHAP) and in dissolved Ca phosphate precipitates of urine or AS (DP) (n = 8, x ± SD).
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high recurrence rates of stone formation. At such states of chronic urinary supersaturation, 
crystallization already can start in the descending loop of Henle and crystals during their way 
through the nephron can stick to tubular walls and by sedimentation can accumulate further 
crystals. Tubular cells damaged by massive crystalluria favor crystal sticking and produce 
pathological UMs, which enhance crystal AGN. Crystal accumulates are ideal platforms for 
the adsorption of UMs and their self-AGN and thus for crystal AGN. By such mechanisms, 
large crystal plugs can be formed which when protruding out from ducts of Bellini into the 
renal calices may give raise to stone formation. Whereas in hyperparathyroidism nephrolithi-
asis can be cured by parathyroidectomy, the treatment of primary hyperoxaluria is extremely 
difficult but not the topic of this chapter. However, in stone metaphylaxis, a high fluid intake 
is essential which apart from urinary supersaturation also reduces ionic strength and urinary 
transit time through the collecting ducts and the renal pelvis.
The formation of Randall’s plaques (RPLs) being the origin of most idiopathic Ca stones 
seems to be a complex process of biomineralization. RPLs are frequent but not always con-
nected with stone disease. Even in the case of nephrolithiasis, stone formation on a RPL can 
take decades, whereas other RPLs in the same kidney can remain stone free [13]. Idiopathic 
Ca nephrolithiasis often is characterized by long stone free intervals [50]. In these cases, stone 
formation seems more to be the result of a coincidence of noisy factors than a real disease. 
A most dangerous constellation is an excessive ingestion of Ox rich food (e.g., chocolate) in 
combination with a poor fluid intake. After excessive Ox intake, a threefold increase of uri-
nary Ox was observed [23]. High urinary Ox and consecutive crystal concentrations can, as 
mentioned above, induce the secretion of pathological UMs and destroy epithelial layers of 
RPLs. The consequence is that HAP deposits come in contact with crystals in a concentrated 
urine where self-AGN and AGN are enhanced by a high ionic strength and a high UM con-
centration. Therefore, for idiopathic Ca stone patients, dietary Ox restriction and a high fluid 
intake are mandatory. However, only the last measure is evidence based [51]; since in stud-
ies of stone metaphylaxis, the compliance of patients especially of those with long stone-free 
intervals often is rather poor.
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